BIOMAT Database Logo BIOMAT Database Logo

[Melanoleukoderma following treatment with hydroquinone monobenzylether]. 1968

K Balabanow, and A L Durmischev, and I Tschernozemsky

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010859 Pigmentation Disorders Diseases affecting PIGMENTATION, including SKIN PIGMENTATION. Incontinentia Pigmenti Achromians,Ito Syndrome,Schamberg's Disease,Schamberg Disease,Disease, Schamberg,Disease, Schamberg's,Disorder, Pigmentation,Disorders, Pigmentation,Pigmentation Disorder,Schambergs Disease,Syndrome, Ito
D005006 Ethnicity A group of people with a common cultural heritage that sets them apart from others in a variety of social relationships. Ethnic Groups,Nationality,Ethnic Group,Nationalities
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006873 Hydroquinones Derivatives of hydroquinone (1,4-dihydrobenzene) made by reduction of BENZOQUINONES. Quinol,p-Dihydroxybenzenes,para-Dihydroxybenzenes,Quinols,p Dihydroxybenzenes,para Dihydroxybenzenes
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014820 Vitiligo A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.

Related Publications

K Balabanow, and A L Durmischev, and I Tschernozemsky
[Treatment of hyperpigmentation with hydroquinone monobenzylether ointment].
May 1959, Zeitschrift fur Haut- und Geschlechtskrankheiten,
K Balabanow, and A L Durmischev, and I Tschernozemsky
Monobenzylether of hydroquinone.
December 1978, The British journal of dermatology,
K Balabanow, and A L Durmischev, and I Tschernozemsky
[Dyschromia caused by monobenzylether of hydroquinone].
October 1959, Revista de la Asociacion Medica Argentina,
K Balabanow, and A L Durmischev, and I Tschernozemsky
[Depigmentation resulting from the application of hydroquinone-monobenzylether].
February 1958, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
K Balabanow, and A L Durmischev, and I Tschernozemsky
[Leucodermia acquisita areata caused by monobenzylether of hydroquinone (author's transl)].
February 1979, Ceskoslovenska dermatologie,
K Balabanow, and A L Durmischev, and I Tschernozemsky
A note on the depigmentary properties of monobenzylether of hydroquinone.
November 1953, The British journal of dermatology,
K Balabanow, and A L Durmischev, and I Tschernozemsky
MONOBENZYLETHER OF HYDROQUINONE. ITS EFFECTS ON THE ACTIVITY OF EPIDERMAL MELANOCYTES.
July 1964, Archives of dermatology,
K Balabanow, and A L Durmischev, and I Tschernozemsky
[Practical experiences with a hydroquinone monobenzylether preparation and a sunscreening agent in hyperpigmentations and light dermatoses].
September 1967, Zeitschrift fur Haut- und Geschlechtskrankheiten,
K Balabanow, and A L Durmischev, and I Tschernozemsky
Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature.
December 1977, The British journal of dermatology,
K Balabanow, and A L Durmischev, and I Tschernozemsky
[Leukomelanodermia areata (dyschromia "en confetti") caused by the application of monobenzylether of hydroquinone (author's transl)].
October 1981, Ceskoslovenska dermatologie,
Copied contents to your clipboard!